Skip to main content
. 2018 Jan 1;24(1-2):57–67. doi: 10.1089/ten.tea.2016.0527

FIG. 5.

FIG. 5.

(A) Immunostaining and (B) quantification of elastin expression in infarcts treated with miR-29B and miR-239B. Scale bar: 100 μm. A significantly decreased presence of elastin was revealed in the border zone of infarcts treated with the miR-29B compared with infarcts treated with miR-29B (*p < 0.05). (C) Immunostaining for detection of blood vessel density within myocardial scars and (D) quantification of vessel density within myocardial scars. A strong trend was detected toward increased vascularity at both the border zone (p = 0.19) and center of the infarcts (p = 0.09) of hearts treated with miR-29B compared with control treatments (miR-239B).